0001209191-19-025413.txt : 20190419
0001209191-19-025413.hdr.sgml : 20190419
20190419213840
ACCESSION NUMBER: 0001209191-19-025413
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190125
FILED AS OF DATE: 20190419
DATE AS OF CHANGE: 20190419
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Nance Mark E
CENTRAL INDEX KEY: 0001755882
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35902
FILM NUMBER: 19758444
MAIL ADDRESS:
STREET 1: 1333 S SPECTRUM BLVD #100
CITY: CHANDLER
STATE: AZ
ZIP: 85286
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Insys Therapeutics, Inc.
CENTRAL INDEX KEY: 0001516479
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 510327886
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 10220 SOUTH 51ST STREET
STREET 2: SUITE 2
CITY: PHOENIX
STATE: AZ
ZIP: 85044
BUSINESS PHONE: 602-910-2617
MAIL ADDRESS:
STREET 1: 10220 SOUTH 51ST STREET
STREET 2: SUITE 2
CITY: PHOENIX
STATE: AZ
ZIP: 85044
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-01-25
0
0001516479
Insys Therapeutics, Inc.
INSY
0001755882
Nance Mark E
1333 S SPECTRUM BLVD #100
CHANDLER
AZ
85286
0
1
0
0
Chief Legal Officer & Gen Cnsl
Common Stock
2019-01-25
4
A
0
10000
0.00
A
25000
D
Employee Stock Option (right to buy)
3.81
2019-01-25
4
A
0
70000
0.00
A
2029-01-24
Common Stock
70000
70000
D
The option vests in 48 equal monthly installments and will be fully vested and exercisable on January 25, 2023.
/s/ Mark E. Nance
2019-04-19